Skip to content
Search

Latest Stories

Submit Guest Post

Bangladesh builds field hospital in three weeks to treat COVID-19 patients

Bangladesh has prepared a huge field hospital in three weeks to treat COVID-19 patients in an attempt to fight the intensifying outbreak in the country.

The South Asian nation has reported nearly 18,000 infections and 269 deaths from COVID-19 despite a countrywide lockdown, but critics say the numbers are far lower than the true virus figures because of insufficient testing.


Only a handful of state-run hospitals in Bangladesh are currently treating coronavirus patients, and officials are hoping the new 2,084-bed facility in the capital Dhaka will help ease pressure on the country's healthcare infrastructure.

"If we can manage necessary manpower, we will be able to provide much better service in this isolation centre," the hospital's director Ehsanul Haq said, referring to the more than 4,000 healthcare workers needed before it can start operations.

The 2,084-bed Bashundhara Convention Centre Grid Hospital (BCCGH) comprises three convention centres and a large temporary structure at a 2.5 million square-foot compound lent by the Bashundhara Group, one of the largest private companies in Bangladesh.

With fears rising in Bangladesh about a massive spike in cases, the hospital's ability to more than double its capacity to 5,000 beds is likely to prove useful to authorities.

The project's executive engineer Masudul Alam said it was inspired by the makeshift hospitals built at breakneck speed in the central Chinese city of Wuhan, where the coronavirus first emerged late last year before spreading around the world.

Alam said 250 people "worked 24/7" to help build the 290 million taka ($3.4 million) facility in three weeks.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less